相关实验视频

Updated: Jun 28, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

对亲瘤性c-RAF-PDE8A复合体的破坏代表了治疗依赖KRAS-c-RAF的PDAC的差异化方法

Sean F Cooke¹, Thomas A Wright¹, Yuan Yan Sin¹

¹College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, UK.

Scientific reports

|April 18, 2024

概括

一种新,DRx-170,破坏c-RAF-PDE8A相互作用,抑制胰腺癌细胞的生长. 这为KRAS突变胰腺管腺癌 (PDAC) 提供了新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

胰腺管腺癌 (PDAC) 是癌症死亡的主要原因,治疗选择有限.
由RAS驱动的癌症,包括KRAS突变PDAC,依赖c-RAF的生长和生存.
向致癌分子通路对于开发新型PDAC疗法至关重要.

研究的目的:

为了研究DRx-170的治疗潜力,这是一种新型的干扰者c-RAF-PDE8A蛋白质-蛋白质相互作用 (PPI).
评估DRx-170在抑制KRAS-c-RAF依赖PDAC的疗效.
探索DRx-170与阿法提尼布的联合治疗,以加强PDAC治疗.

主要方法:

使用了一种新的细胞透,DRx-170,旨在破坏c-RAF-PDE8A PPI.
评估了DRx-170对通过依赖PKA酸化的全性机制对c-RAF无活化的影响.
在2D和3D模型中评估了DRx-170对KRAS突变PDAC细胞系 (PANC1) 增殖,粘附和迁移的影响.
研究了将DRx-170与阿法提尼布结合的协同效应.

主要成果:

DRx-170有效地抑制了PANC1细胞的增殖,粘附和迁移,独立于ERK1/2活动.
由于DRx-170破坏了c-RAF-PDE8A复合体,导致c-RAF失活.
与DRx-170和阿法提尼布的联合治疗显著增强了PANC1生长抑制.
在PDAC模型中,DRx-170灵敏度与c-RAF依赖度相关.

结论:

DRx-170代表了一种新的治疗策略,针对KRAS-c-RAF依赖PDAC中的c-RAF-cAMP/PKA信号轴.
该的抑制癌细胞功能和增强现有疗法的能力显示出有前途.
为了治疗KRAS突变PDAC,需要进一步开发DRx-170.

关键词:

这是一种破坏性.克拉斯 (Kras) 是一个国家.胰腺管道腺癌瘤蛋白质蛋白质相互作用在 c-RAF-PDE8A 中.

更多相关视频

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...